Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$13.70 -0.76 (-5.26%)
At close: Sep 29, 2026 · 4:00 PM EDT

Arcturus Therapeutics Holdings (ARCT) EBT Margin (2018 - 2026)

Updated

Arcturus Therapeutics Holdings' EBT Margin was -803.82% in Q2 2026, down 771.40 percentage points from -32.42% a year earlier but up 599.92 percentage points from the prior quarter.

Analysis

Arcturus Therapeutics Holdings (ARCT) EBT Margin (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, Arcturus Therapeutics Holdings' EBT Margin was -324.33% through Jun 30, 2026, down 274.89 percentage points year-over-year; for FY2025, it came in at -80.19%, down 27.05 percentage points from FY2024.

  • EBT Margin has now declined for three consecutive years, though with a five-year change of +669.61 percentage points (FY2020 to FY2025).
  • In earlier years, EBT Margin was -53.14% in FY2024 (-36.42 pp), -16.72% in FY2023 (-21.89 pp), 5.17% in FY2022 (+1653.15 pp) and -1647.98% in FY2021 (-898.18 pp).
  • Quarterly EBT Margin has moved between -2208.49% (Q3 2021) and 74.02% (Q4 2022) over five years.
  • Compared with a year earlier, EBT Margin has declined for four straight quarters, with an average year-over-year change of -314.33 percentage points over the last eight quarters.
  • The best year-over-year quarter for EBT Margin over five years was Q2 2022 (a gain of 2605.07 percentage points); the worst was Q1 2026 (a drop of 1355.83 percentage points).
  • Per Business Quant data, ARCT's EBT Margin in the three quarters before Q2 2026 was -1403.74% (Q1 2026), -404.16% (Q4 2025) and -78.41% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 26.66%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 25.18%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -4.11%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 29.63%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.19%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 27.53%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -131.41%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 41.75%
10 Arcturus Therapeutics Holdings 411.00 Mn -403.13 Mn - -803.82%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -803.82%
Mar 31, 2026 -1,403.74%
Dec 31, 2025 -404.16%
Sep 30, 2025 -78.41%
Jun 30, 2025 -32.42%
Mar 31, 2025 -47.91%
Dec 31, 2024 -131.81%
Sep 30, 2024 -17.09%
Jun 30, 2024 -34.83%
Mar 31, 2024 -69.58%
Dec 31, 2023 -37.09%
Sep 30, 2023 -33.96%
Jun 30, 2023 -494.09%
Mar 31, 2023 63.35%
Dec 31, 2022 74.02%
Sep 30, 2022 -263.79%
Jun 30, 2022 -79.59%
Mar 31, 2022 -975.76%
Dec 31, 2021 -649.72%
Sep 30, 2021 -2,208.49%
API Access

Arcturus Therapeutics Holdings EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=ARCT&period=max&api_key=YOUR_API_KEY